| 1. |
- Li, Bo, et al.
(författare)
-
Fabrication and characterization of bioactive zirconia-based nanocrystalline glass-ceramics for dental abutment
- 2021
-
Ingår i: Ceramics International. - : Elsevier. - 0272-8842 .- 1873-3956. ; 47:19, s. 26877-26890
-
Tidskriftsartikel (refereegranskat)abstract
- Zirconia-based ceramics are becoming a popular biomaterial in dental implantology due to their natural silver-white color, excellent mechanical properties, and good biocompatibility. However, zirconia-based ceramics are biologically inert, which limits their ability to integrate with the surrounding human tissues. To solve this problem, the bioactive elements of calcium (Ca) and phosphorus (P) were doped in high-strength ZrO2-SiO2 nanocrystalline glass-ceramics (NCGCs) to overcome the biological inertness of ZrO2-based ceramics. XRD results showed that tetragonal zirconia (t-ZrO2) and monoclinic zirconia (m-ZrO2) were the only two crystalline phases after spark plasma sintering. Ca and P dopants acted as destabilizer of t-ZrO2, enhancing its transformability to m-ZrO2 during sintering. The amount of t-ZrO2 exerted significant effects on the average flexural strength of the NCGCs. The NCGC with 45 mol% ZrO2 were composed of 64.5 vol% t-ZrO2 and 35.5 vol% m-ZrO2 after sintering at 1230 degrees C. And, the average flexural strength and Vickers hardness of the NCGC was 615 MPa and 1049 HV, respectively. In comparison, the NCGC with 65 mol% ZrO2 were composed of 12.6 vol% t-ZrO2 and 87.4 vol% m-ZrO2 after sintering at 1150 degrees C. The average flexural strength and Vickers hardness of the NCGC was 293 MPa and 839 HV, respectively. Interestingly, the NCGCs exhibited a plastic deformation behavior during flexural strength test, which was different from traditional brittle ceramics. The ion release results demonstrated that Ca2+ and Si4+ ions kept on releasing from the surface of the material. The formation of hydroxyapatite in the in-vitro apatite formation test indicated that the NCGCs had good biological activity. The doped ZrO2-based NCGCs combined moderate strength and good bioactivity. Hence, the NCGCs show promising potential to be used in sub-gingival regions, such as dental abutments.
|
|
| 2. |
- Xu, Bohan, et al.
(författare)
-
Role of VEGFR2 in Mediating Endoplasmic Reticulum Stress Under Glucose Deprivation and Determining Cell Death, Oxidative Stress, and Inflammatory Factor Expression
- 2021
-
Ingår i: Frontiers in Cell and Developmental Biology. - : Frontiers Media SA. - 2296-634X. ; 9
-
Tidskriftsartikel (refereegranskat)abstract
- Retinal pigment epithelium (RPE), a postmitotic monolayer located between the neuroretina and choroid, supports the retina and is closely associated with vision loss diseases such as age-related macular degeneration (AMD) upon dysfunction. Although environmental stresses are known to play critical roles in AMD pathogenesis and the roles of other stresses have been well investigated, glucose deprivation, which can arise from choriocapillary flow voids, has yet to be fully explored. In this study, we examined the involvement of VEGFR2 in glucose deprivation-mediated cell death and the underlying mechanisms. We found that VEGFR2 levels are a determinant for RPE cell death, a critical factor for dry AMD, under glucose deprivation. RNA sequencing analysis showed that upon VEGFR2 knockdown under glucose starvation, endoplasmic reticulum (ER) stress and unfolded protein response (UPR) are reduced. Consistently, VEGFR2 overexpression increased ER stress under the same condition. Although VEGFR2 was less expressed compared to EGFR1 and c-Met in RPE cells, it could elicit a higher level of ER stress induced by glucose starvation. Finally, downregulated VEGFR2 attenuated the oxidative stress and inflammatory factor expression, two downstream targets of ER stress. Our study, for the first time, has demonstrated a novel role of VEGFR2 in RPE cells under glucose deprivation, thus providing valuable insights into the mechanisms of AMD pathogenesis and suggesting that VEGFR2 might be a potential therapeutic target for AMD prevention, which may impede its progression.
|
|
